Clinical Trial Update: Study of Biomarkers of Airway Inflammation (0000-128) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating biomarkers of airway inflammation has completed, sponsored by Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Inflammation

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Airway Inflammation | Phase 1 | Status: COMPLETED